ble of constitutive GDP-GTP exchange, whereas wildfrom COS-7 cells, whereas neither wild-type (GDP bound) Cdc42 nor the dominant-negative Cdc42(T17N) type (GDP bound) Cdc42 was incapable of this interaction. As will be pointed out throughout this study, these mutant showed detectable binding to Cool-1. Likewise, GST-Cdc42(F28L) and GST-Cdc42(Q61L) fusion protwo activated Cdc42 mutants are interchangeable in their abilities to associate with c-Cbl.
Results

breast cancer cell lines (Flanders et al., 2003). We have found that a similar interaction occurs between c-Cbl and Cool-1. An example is shown in
ble of constitutive GDP-GTP exchange, whereas wildfrom COS-7 cells, whereas neither wild-type (GDP bound) Cdc42 nor the dominant-negative Cdc42(T17N) type (GDP bound) Cdc42 was incapable of this interaction. As will be pointed out throughout this study, these mutant showed detectable binding to Cool-1. Likewise, GST-Cdc42(F28L) and GST-Cdc42(Q61L) fusion protwo activated Cdc42 mutants are interchangeable in their abilities to associate with c-Cbl.
teins were able to precipitate Myc-tagged Cool-1 from cell lysates ( Figure 1D , upper images). Mutating the conActivated Cdc42 was also capable of forming a stable complex with Cool-1. The Cool/Pix proteins were origiserved tryptophan within the SH3 domain of Cool-1 did not affect its ability to bind to activated Cdc42 (Figure  nally assumed Figure 1E ). The ability of c-Cbl to associate with activated forms tivated versions of Cdc42. Figure 1C of receptor are not known, although they often can not be attributed to gene amplification, and so they may Implications for the Role of Cdc42 in EGF Receptor arise through an alteration in the normal uptake or degraSignaling and Cell Growth Control dation of the receptor. In light of the present findings, The effects of activated Cdc42 and Cool-1 on Cbl funcit might also be expected that alterations in the normal tion share some similarity with those reported for the functioning of other control points in the trafficking pathhuman Sprouty2 protein, which was recently shown to way of the EGF receptor may contribute to these canbe capable of attenuating EGF receptor ubiquitination cers, for example, as manifested by the aberrant activaand receptor endocytosis, and to cause enhanced EGFstimulated ERK activation (Wong et al., 2002) . However, tion of Cdc42.
